Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study40

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study22

Views

Views
February 20252
March 202514
April 20253
May 20250
June 20250
July 20252
August 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States3
United Kingdom2
Austria1
Barbados1
Spain1
 

Top cities views

Views
Bridgetown1
Council Bluffs1
Dallas1